http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2147895-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e7b92682f573b73737c0880301b690e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-02 |
| filingDate | 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31396c0b6fd1a309b91e4eae17e3fb23 |
| publicationDate | 2000-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2147895-C1 |
| titleOfInvention | Method for treating uncomplicated fractures of the mandible |
| abstract | FIELD: medicine. SUBSTANCE: method involves sequentially applying transcutaneous electric neurostimulation of the inferior alveolar nerve in the vicinity of mental foramen and electromagnetic stimulation with drugs introduced (electromagnetophoresis) in the zone of mandibular fracture and surrounding soft tissues with differentiated parameters depending on the fracture nature, nerve injury degree and pain syndrome intensity with individually selected drugs. EFFECT: accelerated treatment course; reduced risk of inflammatory complications; lower drug consumption. 4 cl, 1 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8065015-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7981611-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017369-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8313908-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE41391-E |
| priorityDate | 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.